Insider trades
Peter S. Kim, Director of Entrada Therapeutics TRDA, has filed 13 purchases and 0 sales on the open market. The latest trade was on 06/10.
Peter S. Kim
Director
- Company
- Entrada Therapeutics TRDA
- First filing
- 23/06/12
- Trades
- 19 trades
- Buys / sales
- 13 / 0
- 12-month net buying
- No record
- Last trade
- 06/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TRDA | Open-market buyAmendment | 24/05/13–24/05/14 | 25/06/18 | 50,000 sh2 trades | $14.64avg. | $731,750 | +74.2% |
| Open-market buy | 24/05/14 | 24/05/16 | 25,000 sh | $14.59 | $364,750 | +37.1% | |
TRDA | Open-market buy | 24/05/08–24/05/09 | 24/05/10 | 4,476 sh2 trades | $14.14avg. | $63,305.04 | +7.1% |
| Open-market buy | 24/04/08 | 24/04/10 | 2,600 sh | $13.57 | $35,282 | +4.3% | |
| Open-market buy | 24/03/28 | 24/04/01 | 1,512 sh | $13.75 | $20,790 | +2.6% | |
TRDA | Open-market buy | 24/03/22–24/03/26 | 24/03/26 | 9,048 sh3 trades | $13.58avg. | $122,898.48 | +18.2% |
TRDA | Open-market buy | 24/03/19–24/03/21 | 24/03/21 | 2,732 sh3 trades | $12.81avg. | $34,995.44 | +5.8% |